Hyderabad, Mar 18 (UNI) Dr Reddy’s Laboratories Limited on Monday announced the launch of its advanced B2B Customer Service Portal “XCEED.”
Fully focused on meeting the growing demand for Dr Reddy’s portfolio of generic Active Pharmaceutical Ingredients (APIs), the customer service portal significantly increases the operational efficiency in doing business with Dr Reddy’s, a company statement here said.
The no-boundaries platform designed based on customers’ insights and feedback, is a huge step forward in providing an advanced customer experience and facilitating collaboration.
Customers are now able to manage the whole business process in real time, from ordering samples to submit and track their orders, but also to closely interact with Dr Reddy’s inter-disciplinary support team and much more. Catering to leading innovator and generic companies across the US., Europe, Latin America, Japan, Korea and other emerging markets, Dr. Reddy’s is recognized as one of the largest API suppliers.
The launch of XCEED gives now instant access to an industry leading portfolio which spans across a wide range of indications and complex molecules such as steroids, peptides or highly potent APIs (HPAPI).
The platform will be presented for the first time to customers during DCAT week in New York from March 18-21, 2019 and will be available to API customers across the globe during the next week, the statement added.